Goldman Sachs’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $281M | Buy |
|
|||||
|
2025
Q2 | $242M | Sell |
|
|||||
|
2025
Q1 | $351M | Sell |
|
|||||
|
2024
Q4 | $327M | Buy |
|
|||||
|
2024
Q3 | $301M | Buy |
|
|||||
|
2024
Q2 | $160M | Buy |
|
|||||
|
2024
Q1 | $174M | Buy |
|
|||||
|
2023
Q4 | $149M | Sell |
|
|||||
|
2023
Q3 | $190M | Sell |
|
|||||
|
2023
Q2 | $314M | Sell |
|
|||||
|
2023
Q1 | $349M | Buy |
|
|||||
|
2022
Q4 | $341M | Buy |
|
|||||
|
2022
Q3 | $237M | Buy |
|
|||||
|
2022
Q2 | $354M | Buy |
|
|||||
|
2022
Q1 | $310M | Buy |
|
|||||
|
2021
Q4 | $212M | Buy |
|
|||||
|
2021
Q3 | $131M | Buy |
|
|||||
|
2021
Q2 | $134M | Buy |
|
|||||
|
2021
Q1 | $87.4M | Sell |
|
|||||
|
2020
Q4 | $138M | Buy |
|
|||||
|
2020
Q3 | $89.9M | Sell |
|
|||||
|
2020
Q2 | $109M | Sell |
|
|||||
|
2020
Q1 | $128M | Buy |
|
|||||
|
2019
Q4 | $151M | Buy |
|
|||||
|
2019
Q3 | $125M | Buy |
|
|||||
|
2019
Q2 | $103M | Sell |
|
|||||
|
2019
Q1 | $112M | Buy |
|
|||||
|
2018
Q4 | $97.6M | Sell |
|
|||||
|
2018
Q3 | $125M | Buy |
|
|||||
|
2018
Q2 | $119M | Sell |
|
|||||
|
2018
Q1 | $120M | Buy |
|
|||||
|
2017
Q4 | $83.2M | Sell |
|
|||||
|
2017
Q3 | $104M | Sell |
|
|||||
|
2017
Q2 | $120M | Sell |
|
|||||
|
2017
Q1 | $137M | Sell |
|
|||||
|
2016
Q4 | $128M | Buy |
|
|||||
|
2016
Q3 | $140M | Buy |
|
|||||
|
2016
Q2 | $138M | Sell |
|
|||||
|
2016
Q1 | $131M | Buy |
|
|||||
|
2015
Q4 | $90.8M | Buy |
|
|||||
|
2015
Q3 | $85.9M | Buy |
|
|||||
|
2015
Q2 | $84.5M | Sell |
|
|||||
|
2015
Q1 | $99.1M | Buy |
|
|||||
|
2014
Q4 | $84M | Sell |
|
|||||
|
2014
Q3 | $111M | Buy |
|
|||||
|
2014
Q2 | $119M | Sell |
|
|||||
|
2014
Q1 | $127M | Buy |
|
|||||
|
2013
Q4 | $102M | Buy |
|
|||||
|
2013
Q3 | $95M | Buy |
|
|||||
|
2013
Q2 | $87.1M | Buy |
|